Concise review: amniotic fluid stem cells: the known, the unknown, and potential regenerative medicine applications
SP Loukogeorgakis, P De Coppi - Stem Cells, 2017 - academic.oup.com
The amniotic fluid has been identified as an untapped source of cells with broad potential,
which possess immunomodulatory properties and do not have the ethical and legal …
which possess immunomodulatory properties and do not have the ethical and legal …
Body fluid-derived stem cells—an untapped stem cell source in genitourinary regeneration
Somatic stem cells have been obtained from solid organs and tissues, including the bone
marrow, placenta, corneal stroma, periosteum, adipose tissue, dental pulp and skeletal …
marrow, placenta, corneal stroma, periosteum, adipose tissue, dental pulp and skeletal …
Human amniotic mesenchymal stem cells to promote/suppress cancer: two sides of the same coin
A Jafari, M Rezaei-Tavirani… - Stem Cell Research & …, 2021 - Springer
Cancer is a leading cause of death in both developed and developing countries, and
because of population growth and aging, it is a growing medical burden worldwide. With …
because of population growth and aging, it is a growing medical burden worldwide. With …
Technological overview of iPS induction from human adult somatic cells
E Bayart, O Cohen-Haguenauer - Current gene therapy, 2013 - ingentaconnect.com
The unlimited proliferation capacity of embryonic stem cells (ESCs) combined with their
pluripotent differentiation potential in various lineages raised great interest in both the …
pluripotent differentiation potential in various lineages raised great interest in both the …
Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential
Mesenchymal stromal cells (MSCs) exhibit antiapoptotic and proangiogenic functions in
models of myocardial infarction which may be mediated by secreted small extracellular …
models of myocardial infarction which may be mediated by secreted small extracellular …
Advancing regenerative cellular therapies in non-scarring alopecia
TC Anudeep, M Jeyaraman, S Muthu, RL Rajendran… - Pharmaceutics, 2022 - mdpi.com
Alopecia or baldness is a common diagnosis in clinical practice. Alopecia can be scarring or
non-scarring, diffuse or patchy. The most prevalent type of alopecia is non-scarring alopecia …
non-scarring, diffuse or patchy. The most prevalent type of alopecia is non-scarring alopecia …
Mesenchymal stem cells of different origin: comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression
D Trivanović, A Jauković, B Popović, J Krstić… - Life Sciences, 2015 - Elsevier
Aims In vitro expansion changes replication and differentiation capacity of mesenchymal
stem cells (MSCs), increasing challenges and risks, while limiting the sufficient number of …
stem cells (MSCs), increasing challenges and risks, while limiting the sufficient number of …
[HTML][HTML] Wnt signaling behaves as a “master regulator” in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells
I D'Alimonte, A Lannutti, C Pipino, P Di Tomo… - Stem Cell Reviews and …, 2013 - Springer
Human amniotic fluid mesenchymal stem cells (huAFMSCs) are emerging as a promising
therapeutic option in regenerative medicine. Here, we characterized huAFMSC phenotype …
therapeutic option in regenerative medicine. Here, we characterized huAFMSC phenotype …
Mesenchymal stem cells from Wharton's jelly and amniotic fluid
MS Joerger-Messerli, C Marx, B Oppliger… - Best Practice & …, 2016 - Elsevier
Highlights•Wharton's jelly (WJ) and amniotic fluid (AF) are more primitive that adult
mesenchymal stem cells (MSC), but not tumorigenic.•Preclinical and clinical studies suggest …
mesenchymal stem cells (MSC), but not tumorigenic.•Preclinical and clinical studies suggest …
Stem cells from amniotic fluid–Potential for regenerative medicine
SP Loukogeorgakis, P De Coppi - … practice & research Clinical obstetrics & …, 2016 - Elsevier
Highlights•Regenerative medicine focusses on replacement, repair and regeneration of
cells, tissues and organs.•Amniotic fluid stem cells (AFSCs) are broadly multipotent, that is …
cells, tissues and organs.•Amniotic fluid stem cells (AFSCs) are broadly multipotent, that is …